Factors Related to Mortality in Patients with COVID-19 during the Early Phase of the Pandemic in Japan: An Observational Study Using the Osaka Prefectural Novel Coronavirus Response Status Management System.

COVID-19 Japan epidemiology mortality underlying disease

Journal

JMA journal
ISSN: 2433-3298
Titre abrégé: JMA J
Pays: Japan
ID NLM: 101769797

Informations de publication

Date de publication:
16 Jul 2024
Historique:
received: 08 11 2023
accepted: 29 02 2024
medline: 8 8 2024
pubmed: 8 8 2024
entrez: 8 8 2024
Statut: ppublish

Résumé

Elucidating the epidemiological picture in the early phase of a pandemic is crucial to strengthening preparedness and public health responses to future emerging infectious diseases. Using data from the "Osaka Prefectural Novel Coronavirus Response Status Management System," we evaluated factors associated with mortality among patients with novel coronavirus disease 2019 (COVID-19) in Osaka Prefecture, Japan. The study periods were from January 29 to June 13, 2020 (first surge), from June 14 to October 9, 2020 (second surge), and from October 10 to December 24, 2020 (up to the middle of the third surge). The odds ratios (ORs) and 95% confidence intervals (95% CIs) for mortality were calculated using logistic regression models. Of the 14,864 patients with COVID-19 (8,207 men, 6,657 women) registered, 297 (2%) died. The ORs for mortality were significantly higher in men (OR = 2.00, 95% CI = 1.54-2.60) than in women, in 70- to 79-year-olds (OR = 25.4, 95% CI = 16.8-38.2) and ≥80-year-olds (OR = 78.1, 95% CI = 53.3-114) than in 0- to 69-year-olds ( Among those affected early in the COVID-19 epidemic, male sex, older age, first-surge infection, and underlying medical conditions were significantly associated with mortality. Our findings are expected to provide a useful reference for future countermeasures in the early stages of pandemics involving unknown emerging infectious diseases.

Identifiants

pubmed: 39114622
doi: 10.31662/jmaj.2023-0179
pmc: PMC11301106
doi:

Types de publication

Journal Article

Langues

eng

Pagination

364-374

Informations de copyright

Copyright © Japan Medical Association.

Déclaration de conflit d'intérêts

None

Auteurs

Kyoko Kondo (K)

Management Bureau, Osaka Metropolitan University Hospital, Osaka, Japan.
Research Support Platform, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Asae Suita (A)

Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Satoko Ohfuji (S)

Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Research Center for Infectious Disease Sciences, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Emiko Mukai (E)

Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Tetsuo Kase (T)

Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Research Center for Infectious Disease Sciences, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Wakaba Fukushima (W)

Research Support Platform, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Research Center for Infectious Disease Sciences, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Osaka International Research Center for Infectious Diseases, Osaka Metropolitan University, Osaka, Japan.

Classifications MeSH